$50.00 – $90.00
Trenbolone Acetate (Tren A) is a highly androgenic/anabolic steroid (AAS) and a potent agonist of androgen receptors which has been extensively used as a growth promoter. Tren A is a progestin and does not convert to estrogen. The effects of Trenbolone Acetate are increased weight gain, increased aggression, sweating, insomnia, increased muscle hardness, improved food conversion efficiency, decreased muscle RNA and DNA concentrations and decreased free cathepsin D activity in muscle. The half-life of Trenbolone Acetate in circulation is 24 hours.
Trenbolone Acetate (Tren A) is available in three variants: Tren-A 100mg, Tren-A 150mg, Tren-A 200mg. Bulk oil orders (250ml and 500ml) are packed in sterile aluminium canisters.
You can also view our list of injectable steroids for other injectable variants
|EACH ML CONTAINS:|
|Grape Seed Oil||BP||q.s.|
Dosage and administration:
Half life 24 hours
Adult dose (Male) 50-200mg ED or EOD by intramuscular injection
Adult dose (Female) 25-50mg ED or EOD by intramuscular injection
Average Cycle Length: 4-16 weeks following and ED or ED injection regime
Anabolic #: 500
Androgenic #: 500
Bioavailability: Estimated at 100%
CAS Name: 17-Hydroxyestra-4,9,11-trien-3-one
Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia.
Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant.
Genitourinary System In males:
Drug/Laboratory test interactions
Therapy with Trenbolone Acetate may decrease thyroxine-binding globulin resulting in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged. Increased creatine and creatinine excretion, increased serum levels of creatinine phosphokinase (CPK).